We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Oversight Committee Leaders Ask FDA For Documents On Proposed Generics Labeling Rule
Oversight Committee Leaders Ask FDA For Documents On Proposed Generics Labeling Rule
The FDA has been asked to turn over a trove of information related to the development of its proposed generic drug labeling rule, with GOP leaders of a key House investigative committee claiming the agency engaged in “dubious” behaviors in the rulemaking process.
